SCHEMBL8008100

SCHEMBL8008100

c1csc(CN2CCC(N3c4ccccc4CSc4ccccc43)CC2)c1

nearest known ligand 0.45

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
DRD4 P21917 6/20 0.45
DRD3 P35462 5/20 0.45
DRD2 P14416 3/20 0.45
CHRM2 P08172 1/20 0.43
CHRM3 P20309 1/20 0.43
SIGMAR1 Q99720 2/20 0.43
HTT P42858 1/20 0.43
PARP2 Q9UGN5 1/20 0.42
OPRM1 P35372 1/20 0.42
OPRK1 P41145 1/20 0.42
OPRL1 P41146 1/20 0.42
KDM4E B2RXH2 1/20 0.42
ALDH1A1 P00352 1/20 0.42
POLB P06746 1/20 0.42
MAPT P10636 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
DRD5 P21918 1/20 0.40
PARP1 P09874 3/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8025512 0.83 OPRL1 (0.60) DRD4DRD3DRD2CHRM3SIGMAR1
SCHEMBL8025463 0.82 OPRM1 (0.50) DRD4DRD3DRD2SIGMAR1OPRM1
SCHEMBL8025530 0.80 OPRM1 (0.50) DRD4DRD2SIGMAR1OPRM1OPRK1
SCHEMBL5111674 0.77 DRD4 (0.43) DRD4DRD3DRD2CHRM2CHRM3
SCHEMBL8020392 0.76 ALDH1A1 (0.42) DRD4DRD3DRD2OPRM1OPRK1
SCHEMBL8018967 0.75 KCNH2 (0.45) DRD4DRD3DRD2CHRM2CHRM3
SCHEMBL8018527 0.74 OPRM1 (0.52) DRD3DRD2CHRM2CHRM3SIGMAR1
SCHEMBL8018530 0.74 OPRM1 (0.52) DRD3DRD2CHRM2CHRM3SIGMAR1
SCHEMBL8021216 0.73 DRD2 (0.41) DRD4DRD3DRD2OPRM1OPRK1
SCHEMBL8008566 0.73 OPRM1 (0.46) DRD4DRD3DRD2CHRM2CHRM3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6063779-A CARDIOVASCULAR DISORDERS MEIJI SEIKA KAISHA, LTD. (JP) 2000-05-16 US disclosed
EP-0878475-A2 5-(4-Piperidinyl)dibenzothiazepine derivatives and 5-(4-piperidinyl)dibenzoxazepine derivatives, and antiarrhythmic agents Meiji Seika Kaisha, Ltd. (JP) 1998-11-18 EP disclosed